Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Siponimod. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Siponimod avoids hazardous diazotization and chromatography, offering cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Patent CN115784839B details a cost-effective Heck coupling route for Siponimod intermediates, offering scalable manufacturing and enhanced supply chain reliability.